Fresenius Medical Care (NYSE:FMS) Shares Gap Down - Should You Sell?

Fresenius Medical Care AG (NYSE:FMS - Get Free Report) shares gapped down prior to trading on Thursday . The stock had previously closed at $24.19, but opened at $23.35. Fresenius Medical Care shares last traded at $23.21, with a volume of 31,033 shares traded.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Truist Financial raised their target price on Fresenius Medical Care from $23.00 to $25.00 and gave the company a "hold" rating in a research note on Monday, January 6th. Bank of America upgraded shares of Fresenius Medical Care from an "underperform" rating to a "neutral" rating in a research report on Monday, December 2nd. Finally, StockNews.com upgraded shares of Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 5th.

Fresenius Medical Care Stock Performance

The firm's 50-day moving average price is $23.70 and its two-hundred day moving average price is $22.24. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $14.19 billion, a PE ratio of 19.99, a P/E/G ratio of 0.76 and a beta of 0.99.

Institutional Trading of Fresenius Medical Care

Large investors have recently added to or reduced their stakes in the company. Venturi Wealth Management LLC boosted its position in shares of Fresenius Medical Care by 8.4% in the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock worth $129,000 after buying an additional 441 shares during the period. PNC Financial Services Group Inc. boosted its position in Fresenius Medical Care by 5.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 9,278 shares of the company's stock worth $210,000 after acquiring an additional 442 shares during the period. MML Investors Services LLC grew its stake in Fresenius Medical Care by 5.3% during the 3rd quarter. MML Investors Services LLC now owns 15,019 shares of the company's stock valued at $320,000 after acquiring an additional 753 shares in the last quarter. Smartleaf Asset Management LLC increased its holdings in shares of Fresenius Medical Care by 192.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock valued at $28,000 after purchasing an additional 806 shares during the period. Finally, DAVENPORT & Co LLC increased its holdings in shares of Fresenius Medical Care by 1.5% in the 4th quarter. DAVENPORT & Co LLC now owns 58,147 shares of the company's stock valued at $1,316,000 after purchasing an additional 862 shares during the period. 8.37% of the stock is owned by institutional investors and hedge funds.

Remove Ads

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.